Radiance Antibacterial Plum Foam Handwash
NDC Package 71925-400-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Radiance Antibacterial Plum Foam Handwash is a . Marketed by Pollock Investments Incorporated, this product is identified by NDC 71925-400 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
71925-400-40
Package Description
1200 mL in 1 PACKAGE
Product Code
11-Digit Billing Format
71925040040

Clinical Specifications

Proprietary Name
Radiance Antibacterial Plum Foam Handwash
Dosage Form
-

Regulatory & Marketing

Labeler Name
Pollock Investments Incorporated
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-30-2017
End Marketing Date
07-31-2025
Listing Expiration
07-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (71925-400). Click a package code to view its specific billing and regulatory data.

1250 mL in 1 PACKAGE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71925-400-40 identifies a specific commercial package of 1200 ml in 1 package of Radiance Antibacterial Plum Foam Handwash, labeled by Pollock Investments Incorporated. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pollock Investments Incorporated on April 30, 2017. The current certification is valid through July 31, 2025.

How is this Pollock Investments Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71925040040. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71925-400-40
11-Digit CMS (5-4-2)
71925-0400-40

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.